Chronic obstructive pulmonary disease (COPD) patients' disease-related preferences: A study using conjoint analysis

Patient

Volumn 6, Issue 2, 2013, Pages 93-101

  Pisa, Giovanni ^a   Freytag, Siegfried ^a   Schandry, Rainer ^b  

^a KANTAR HEALTH   (United States)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATTITUDE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT TOOL; DISEASE SEVERITY; DYSPNEA; EMOTION; FEMALE; GERMANY; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PATIENT PREFERENCE; PRIORITY JOURNAL; QUALITATIVE RESEARCH; QUALITY OF LIFE; SELF EVALUATION; SLEEP QUALITY;

ADULT; AGED; BAYES THEOREM; DATA INTERPRETATION, STATISTICAL; FEMALE; GERMANY; HEALTH STATUS; HUMANS; INTERVIEWS AS TOPIC; LOGISTIC MODELS; MALE; MIDDLE AGED; PATIENT PREFERENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 84880085303     PISSN: 11781653     EISSN: 11781661     Source Type: Journal    
DOI: 10.1007/s40271-013-0007-2     Document Type: Article

References (26)

1. WHO. Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach. Geneva: World Health Organization; 2007.
2. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370(9589):765-73.
3. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442.
4. Mittmann N, Kuramoto L, Seung, et al. The cost of moderate and severe COPD exacerbations to the Canadian healthcare system. Respir Med. 2008;102(3):413-21.
5. Agh T, Inotai A, Meszaros A. Factors associated with medication adherence in patients with chronic obstructive pulmonary disease. Respiration. 2011;82(4):328-34.
6. Dolce JJ, Crisp C, Manzella B, et al. Medication adherence patterns in chronic obstructive pulmonary disease. Chest. 1991;99(4):837-41.
7. Bosley CM, Parry DT, Cochrane GM. Patient compliance with inhaled medication: does combining beta-agonists with corticosteroids improve compliance? Eur Respir J. 1994;7(3):504-9.
8. Lorig KR, Sobel DS, Stewart AL, et al. Evidence suggesting that a chronic disease self-management program can improve health status while reducing hospitalization: a randomized trial. Med Care. 1999;37(1):5-14.
9. Hyland ME, Stahl E. Asthma treatment needs: a comparison of patients' and health care professionals' perceptions. Clin Ther. 2004;26:2141-52.
10. Ryan M. Discrete choice experiments in health care. BMJ. 2004;14(328):360-1.
11. Ryan M, Farrar S. Using conjoint analysis to elicit preferences for health care. BMJ. 2000;320(7248):1530-3.
12. Haughney J, Partridge MR, Vogelmeier C, et al. Exacerbations of COPD: quantifying the patient's perspective using discrete choice modelling. Eur Respir J. 2005;26(4):623-9.
13. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. GOLD; 2011. http://www.goldcopd.org/uploads/users/files/GOLD-Report- 2011-Feb21.pdf. Accessed 30 Jan 2013.
14. McFadden D, Train K. Mixed MNL models for discrete response. J Appl Econ. 2000;15(5):447-70.
15. Kuhfeld WF. Marketing research methods in SAS: experimental design, choice, conjoint, and graphical techniques [SAS 9.2 ed.]. Cary (NC): SAS Institute Inc.; 2010.
16. van der Molen T, Willemse BW, Schokker S, Ten Hacken NH, Postma DS, Juniper EF. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes. 2003;1(1):13.
17. Ryan M, Gerard K. Using discrete choice experiments to value health care programmes: current practice and future research reflections. Appl Health Econ Health Policy. 2003;2(1):55-64.
18. Dransfield MT, Bailey W, Crater G, et al. Disease severity and symptoms among patients receiving monotherapy for COPD. Prim Care Respir J. 2011;20(1):46-53.
19. Kinsman RA, Yaroush RA, Fernandez E, et al. Symptoms and experiences in chronic bronchitis and emphysema. Chest. 1983;83(5):755-61.
20. Rutten-van Molken MP, Oostenbrink JB, Tashkin DP, et al. Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages? Chest. 2006;130(4):1117-28.
21. Jehn M, Schindler C, Meyer A, et al. Daily walking intensity as a predictor of quality of life in patients with COPD. Med Sci Sports Exerc. 2012;44(7):1212-8.
22. Agusti A, Hedner J, Marin JM, et al. Night-time symptoms: a forgotten dimension of COPD. Eur Respir Rev. 2011;20(21):183-94.
23. Partridge MR, Karlsson N, Small IR. Patient insight into the impact of chronic obstructive pulmonary disease in the morning: an internet survey. Curr Med Res Opin. 2009;15(8):2043-8.
24. Nunes DM, Mota RM, de Pontes Neto OL, et al. Impaired sleep reduces quality of life in chronic obstructive pulmonary disease. Lung. 2009;187(3):159-63.
25. Jones PW, Agusti AG. Outcomes and markers in the assessment of chronic obstructive pulmonary disease. Eur Respir J. 2006;27(4):822-32.
26. Stege G, Vos PJ, van den Elshout FJ, et al. Sleep, hypnotics and chronic obstructive pulmonary disease. Respir Med. 2008;102(6):801-14.